Exploring different strategies for efficient delivery of colorectal cancer therapy

Congcong Lin, Huei Leng Helena Ng, Weisan Pan, Hubiao CHEN, Ge ZHANG, Zhaoxiang BIAN, Aiping LYU*, Zhijun YANG*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

33 Citations (Scopus)


Colorectal cancer (CRC) is the third most common cancer and the fourth leading cause of cancer death in the world. Currently available chemotherapy of CRC usually delivers the drug to both normal as well as cancerous tissues, thus leading to numerous undesirable effects. Much emphasis is being laid on the development of effective drug delivery systems for achieving selective delivery of the active moiety at the anticipated site of action with minimized unwanted side effects. Researchers have employed various techniques (dependent on pH, time, pressure and/or bacteria) for targeting drugs directly to the colonic region. On the other hand, systemic drug delivery strategies to specific molecular targets (such as FGFR, EGFR, CD44, EpCAM, CA IX, PPAR and COX-2) overexpressed by cancerous cells have also been shown to be effective. This review aims to put forth an overview of drug delivery technologies that have been, and may be developed, for the treatment of CRC.

Original languageEnglish
Pages (from-to)26936-26952
Number of pages17
JournalInternational Journal of Molecular Sciences
Issue number11
Publication statusPublished - 11 Nov 2015

Scopus Subject Areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

User-Defined Keywords

  • Chemotherapy
  • Colon-specific drug delivery system
  • Colorectal cancer
  • Drug delivery system
  • Systemic drug delivery system


Dive into the research topics of 'Exploring different strategies for efficient delivery of colorectal cancer therapy'. Together they form a unique fingerprint.

Cite this